Back to Screener

Healthcare

Zelira Therapeutics Limited(ZLDAF)

Live Price

Offline

$0.35

+0.00% today

1Y Change

+25.36%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
$10.00M
Revenue Growth
-99.3%
EPS Growth
+90.1%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Zelira Therapeutics Limited (ZLDAF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.35 and up 25.4% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of -99.3%, EPS growth of +90.1%, a dividend yield of 0.0%. What stands out right now is revenue -99.3%, EPS +90.1%, free cash flow -11.8% with operating margin -663833.7% and ROIC 202.3%. Valuation already assumes a fairly strong business story at price/sales 9081.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ZLDAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

ZLDAF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

ZLDAF Max Drawdown

-33.16%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ZLDAF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedFeb 24, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Feb 24, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Feb 24
โ€”
Sep 1, 25
-0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Sep 1
โ€”
Feb 26, 25
-0.13
Est โ€”
โ€”
405M
Est โ€”
โ€”
Feb 26
โ€”
Oct 29, 24
-0.14
Est โ€”
โ€”
26.8B
Est โ€”
โ€”
Oct 29
โ€”
Apr 29, 24
-2.05
Est โ€”
โ€”
37.3B
Est โ€”
โ€”
Apr 29
โ€”
Jun 30, 23
-0.14
Est โ€”
โ€”
148.9B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 22
-0.23
Est โ€”
โ€”
52.6B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 22
-0.48
Est โ€”
โ€”
558.9B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 21
-0.52
Est โ€”
โ€”
527.5B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 21
-0.55
Est โ€”
โ€”
430.1B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 20
-0.44
Est โ€”
โ€”
69.4B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 20
-0.59
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 19
-0.42
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 19
-0.24
Est โ€”
โ€”
537.6B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 18
-0.37
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 18
-0.20
Est โ€”
โ€”
173.3B
Est โ€”
โ€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener